CLINICAL_TRIALS
withdrawal
· 2015-12-11
Clinical Trial Update: A Study of the Safety and Tolerability of Intravitreal LKA651 in Patients With Diabetic Macular Edema [Phase 1]
Summary
Phase 1 study evaluating intravitreal LKA651 for diabetic macular edema has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alcon Research | Conditions: Diabetic Macular Edema | Phase 1 | Status: WITHDRAWN